ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 128 filers reported holding ANAPTYSBIO INC in Q2 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,403,661 | -3.0% | 56,012 | -12.8% | 0.00% | – |
| Q1 2024 | $1,446,685 | +27.2% | 64,240 | +20.9% | 0.00% | – |
| Q4 2023 | $1,137,702 | -12.7% | 53,114 | -26.8% | 0.00% | – |
| Q3 2023 | $1,303,285 | -11.5% | 72,566 | +0.2% | 0.00% | -100.0% |
| Q2 2023 | $1,472,759 | +88727.4% | 72,407 | -5.0% | 0.00% | 0.0% |
| Q1 2023 | $1,658 | -66.5% | 76,215 | -52.3% | 0.00% | -50.0% |
| Q4 2022 | $4,949 | -99.9% | 159,694 | -29.9% | 0.00% | 0.0% |
| Q3 2022 | $5,810,000 | +13.7% | 227,782 | -9.5% | 0.00% | 0.0% |
| Q2 2022 | $5,111,000 | -53.3% | 251,804 | -39.0% | 0.00% | -50.0% |
| Q1 2022 | $10,935,000 | -23.8% | 412,647 | -0.1% | 0.00% | 0.0% |
| Q4 2021 | $14,356,000 | +25.8% | 413,131 | -1.9% | 0.00% | 0.0% |
| Q3 2021 | $11,416,000 | +7.8% | 420,949 | +3.1% | 0.00% | +33.3% |
| Q2 2021 | $10,589,000 | +30.1% | 408,356 | +8.1% | 0.00% | 0.0% |
| Q1 2021 | $8,139,000 | +140.6% | 377,707 | +140.1% | 0.00% | +200.0% |
| Q4 2020 | $3,383,000 | +1.7% | 157,324 | -30.3% | 0.00% | 0.0% |
| Q3 2020 | $3,327,000 | -35.6% | 225,604 | -2.4% | 0.00% | -50.0% |
| Q2 2020 | $5,163,000 | +63.4% | 231,143 | +3.4% | 0.00% | 0.0% |
| Q1 2020 | $3,160,000 | +0.5% | 223,605 | +15.6% | 0.00% | +100.0% |
| Q4 2019 | $3,144,000 | -9.5% | 193,477 | +94.9% | 0.00% | 0.0% |
| Q3 2019 | $3,473,000 | -38.0% | 99,265 | -0.1% | 0.00% | -50.0% |
| Q2 2019 | $5,606,000 | – | 99,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $53,362,000 | 8.10% |
| EcoR1 Capital, LLC | 7,521,024 | $152,677,000 | 5.27% |
| GREAT POINT PARTNERS LLC | 453,118 | $9,198,000 | 2.21% |
| Soleus Capital Management, L.P. | 643,575 | $13,065,000 | 2.04% |
| Frazier Life Sciences Management, L.P. | 899,700 | $18,264,000 | 1.72% |
| Boxer Capital, LLC | 1,300,000 | $26,390,000 | 1.67% |
| Deep Track Capital, LP | 672,569 | $13,653,000 | 0.90% |
| Palo Alto Investors LP | 431,024 | $8,750,000 | 0.76% |
| TCG Crossover Management, LLC | 58,515 | $1,188,000 | 0.50% |
| HighVista Strategies LLC | 33,103 | $672,000 | 0.41% |